Return on investment for bariatric surgery.

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMID 18778170)

Published in Am J Manag Care on September 01, 2008

Authors

Eric A Finkelstein, Derek S Brown

Articles citing this

Return on investment for bariatric surgery. Am J Manag Care (2008) 0.86

Articles cited by this

A study on the economic impact of bariatric surgery. Am J Manag Care (2008) 2.83

Articles by these authors

The economic burden of child maltreatment in the United States and implications for prevention. Child Abuse Negl (2012) 3.18

Environment, obesity, and cardiovascular disease risk in low-income women. Am J Prev Med (2006) 2.39

The lifetime medical cost burden of overweight and obesity: implications for obesity prevention. Obesity (Silver Spring) (2008) 2.31

Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring) (2008) 2.23

Cost effectiveness of internet interventions: review and recommendations. Ann Behav Med (2009) 2.21

Medical costs and productivity losses due to interpersonal and self-directed violence in the United States. Am J Prev Med (2007) 2.15

Cancer treatment cost in the United States: has the burden shifted over time? Cancer (2010) 2.10

Effect of a stepped-care intervention approach on weight loss in adults: a randomized clinical trial. JAMA (2012) 2.02

Medicaid expenditures on psychotropic medications for maltreated children: a study of 36 States. Psychiatr Serv (2014) 1.99

Public perceptions of childhood obesity. Am J Prev Med (2005) 1.85

Individual and aggregate years-of-life-lost associated with overweight and obesity. Obesity (Silver Spring) (2009) 1.62

A randomized study of financial incentives to increase physical activity among sedentary older adults. Prev Med (2008) 1.61

Considerations for an obesity policy research agenda. Am J Prev Med (2009) 1.57

State-level Medicaid expenditures attributable to smoking. Prev Chronic Dis (2009) 1.50

The economic burden of chronic cardiovascular disease for major insurers. Health Promot Pract (2007) 1.49

State- and payer-specific estimates of annual medical expenditures attributable to obesity. Obesity (Silver Spring) (2011) 1.47

Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology (2003) 1.39

Estimates of incidence rates with longitudinal claims data. Arch Ophthalmol (2003) 1.37

Youth BMI trajectories: evidence from the NLSY97. Obesity (Silver Spring) (2009) 1.36

Longitudinal prevalence of major eye diseases. Arch Ophthalmol (2003) 1.29

Estimates of state-level health-care expenditures associated with disability. Public Health Rep (2010) 1.25

Monitoring visual status: why patients do or do not comply with practice guidelines. Health Serv Res (2004) 1.20

Use of econometric models to estimate expenditure shares. Health Serv Res (2008) 1.20

Beyond effectiveness: evaluating the public health impact of the WISEWOMAN program. Am J Public Health (2007) 1.17

Health promotion interventions for disadvantaged women: overview of the WISEWOMAN projects. J Womens Health (Larchmt) (2004) 1.16

Young adult weight trajectories through midlife by body mass category. Obesity (Silver Spring) (2013) 1.15

Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung. Cancer (2011) 1.10

Comparing cost-of-illness estimates from alternative approaches: an application to diabetes. Health Serv Res (2009) 1.08

Health care costs associated with child maltreatment: impact on medicaid. Pediatrics (2013) 1.07

Insurance coverage and incentives for weight loss among adults with metabolic syndrome. Obesity (Silver Spring) (2008) 1.02

Spatial analysis of body mass index and smoking behavior among WISEWOMAN participants. J Womens Health (Larchmt) (2004) 1.00

Adherence to guidelines and its effects on hospitalizations with complications of type 2 diabetes. Rev Diabet Stud (2004) 1.00

Methods for estimating medical expenditures attributable to intimate partner violence. J Interpers Violence (2008) 1.00

Effects of changes in self-reported vision on cognitive, affective, and functional status and living arrangements among the elderly. Am J Ophthalmol (2005) 0.99

Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial. Trials (2014) 0.96

Longitudinal analysis of the relationship between regular eye examinations and changes in visual and functional status. J Am Geriatr Soc (2005) 0.95

A cost-benefit simulation model of coverage for bariatric surgery among full-time employees. Am J Manag Care (2005) 0.95

A cluster randomised controlled trial evaluating an incentive-based outdoor physical activity programme to increase outdoor time and prevent myopia in children. Ophthalmic Physiol Opt (2014) 0.94

Medicaid expenditures on psychotropic medications for children in the child welfare system. J Child Adolesc Psychopharmacol (2012) 0.94

Estimating older adults' preferences for walking programs via conjoint analysis. Am J Prev Med (2009) 0.94

A return-on-investment simulation model of workplace obesity interventions. J Occup Environ Med (2009) 0.91

Changing perceptions of the childhood obesity epidemic. Am J Health Behav (2006) 0.91

Do obese persons comprehend their personal health risks? Am J Health Behav (2008) 0.91

The impact of medication use in a multicomponent intervention: results from the WISEWOMAN program. Am J Health Promot (2007) 0.84

Psychotropic drug use among preschool children in the Medicaid program from 36 states. Am J Public Health (2015) 0.83

The effect of weight loss on health, productivity, and medical expenditures among overweight employees. Med Care (2013) 0.82

Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the Heart to Health study. Contemp Clin Trials (2013) 0.80

Using health-related quality of life and quality-adjusted life expectancy for effective public health surveillance and prevention. Expert Rev Pharmacoecon Outcomes Res (2013) 0.79

Motivation for participating in a weight loss program and financial incentives: an analysis from a randomized trial. J Obes (2012) 0.79

The role of price, sociodemographic factors, and health in the demand for bariatric surgery. Am J Manag Care (2005) 0.78

Why does the private sector underinvest in obesity prevention and treatment? N C Med J (2006) 0.78

Use of behavior change techniques in clean cooking interventions: a review of the evidence and scorecard of effectiveness. J Health Commun (2015) 0.77

One size does not fit all: HIV testing preferences differ among high-risk groups in Northern Tanzania. AIDS Care (2015) 0.77

Adolescent girls' preferences for HPV vaccines: a discrete choice experiment. Adv Health Econ Health Serv Res (2014) 0.77

The Affordable Care Act and Implications for Health Care Services for American Indian and Alaska Native Individuals. J Health Care Poor Underserved (2015) 0.76

Cost Minimization Analysis of Precut Cornea Grafts in Descemet Stripping Automated Endothelial Keratoplasty. Medicine (Baltimore) (2016) 0.75

Prevalence of comorbidities and baseline characteristics of LAP-BAND AP® subjects in the Helping Evaluate Reduction in Obesity (HERO) study. PLoS One (2013) 0.75

Medications for maltreated children: wrong conclusions? In reply. Psychiatr Serv (2015) 0.75

Would you test for 5000 Shillings? HIV risk and willingness to accept HIV testing in Tanzania. Health Econ Rev (2015) 0.75

Predicted patient demand for a new delivery system for glaucoma medicine. Medicine (Baltimore) (2017) 0.75

Knowledge and perceptions among overweight and obese employees about lifestyle-related health benefit changes. N C Med J (2011) 0.75

Control of blood pressure and risk attenuation: a public health intervention in rural Bangladesh, Pakistan, and Sri Lanka: feasibility trial results. J Hypertens (2016) 0.75

Recall of three heart disease risk factor diagnoses among low-income women. J Womens Health (Larchmt) (2009) 0.75

A practical model for economic evaluation of tissue-engineered therapies. Wiley Interdiscip Rev Syst Biol Med (2015) 0.75